Exact Mass: 380.1471
Exact Mass Matches: 380.1471
Found 248 metabolites which its exact mass value is equals to given mass value 380.1471
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Gibberellin A86
Gibberellin A86 (GA86) belongs to the class of organic compounds known as C19-gibberellin 6-carboxylic acids. These are C19-gibberellins with a carboxyl group at the 6-position. Gibberellin A86 is found in fruits. Gibberellin A86 is a constituent of Prunus persica (peaches). Constituent of Prunus persica (peaches). Gibberellin A86 is found in many foods, some of which are peach, sweet cherry, sour cherry, and fruits.
Methyl helianthenoate A glucoside
Methyl helianthenoate A glucoside is found in root vegetables. Methyl helianthenoate A glucoside is a constituent of Helianthus tuberosus (Jerusalem artichoke). Constituent of Helianthus tuberosus (Jerusalem artichoke). Methyl helianthenoate A glucoside is found in root vegetables.
8-Oxodiacetoxyscirpenol
8-Oxodiacetoxyscirpenol is from Fusarium sporotrichioides. From Fusarium sporotrichioides
(S)-Bitalin A 12-glucoside
(S)-Bitalin A 12-glucoside is found in herbs and spices. (S)-Bitalin A 12-glucoside is a constituent of Helichrysum italicum (curry plant). Constituent of Helichrysum italicum (curry plant). (S)-Bitalin A 12-glucoside is found in tea and herbs and spices.
Gibberellin A75
Gibberellin A75 (GA75) belongs to the class of organic compounds known as C19-gibberellin 6-carboxylic acids. These are C19-gibberellins with a carboxyl group at the 6-position. Gibberellin A75 is found in fats and oils. Gibberellin A75 is a constituent of seeds of Helianthus annuus (sunflower). Constituent of seeds of Helianthus annuus (sunflower). Gibberellin A75 is found in sunflower and fats and oils.
Amosulalol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Egtazic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
N-((2-(2-Fluoroethoxy)phenyl)methyl)-N-(4-phenoxy-3-pyridinyl)acetamide
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
[3aR-(3aR*,4S*,5R*,6E,10S*,11R*,11aS*)]-2,3,3a,4,5,8,9,10,11,11a-Decahydro-5,10,11-trihydroxy-6,10-dimethyl-3-methylene-2,9-dioxocyclodeca[b]furan-4-yl ester 2-methyl-2-propenoic acid
CP-457677
CONFIDENCE standard compound; INTERNAL_ID 1093; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8647; ORIGINAL_PRECURSOR_SCAN_NO 8646 CONFIDENCE standard compound; INTERNAL_ID 1093; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8673; ORIGINAL_PRECURSOR_SCAN_NO 8672 CONFIDENCE standard compound; INTERNAL_ID 1093; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8683; ORIGINAL_PRECURSOR_SCAN_NO 8681 CONFIDENCE standard compound; INTERNAL_ID 1093; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8694; ORIGINAL_PRECURSOR_SCAN_NO 8693 CONFIDENCE standard compound; INTERNAL_ID 1093; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8711; ORIGINAL_PRECURSOR_SCAN_NO 8708 CONFIDENCE standard compound; INTERNAL_ID 1093; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8699; ORIGINAL_PRECURSOR_SCAN_NO 8697
3,15-Diacetyldeoxynivalenol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
1,2-O-Ethylidene,4,6-di-Ac,3-benzyl-alpha-D-Pyranose-Allose
3beta,13-diacetoxy-1alpha-hydroperoxygermacra-4E,9Z,7(11)-triene-12,6alpha-olide
6-acetyl-2,2-dimethylchromene-8-O-beta-D-glucopyranoside
8alpha-acetoxy-4alpha,5alpha-epoxyjalcaguaianolide 13-O-acetate
[3aR-(3aR*,4S*,5R*,6E,10S*,11R*,11aS*)]-2,3,3a,4,5,8,9,10,11,11a-Decahydro-5,10,11-trihydroxy-6,10-dimethyl-3-methylene-2,9-dioxocyclodeca[b]furan-4-yl ester 2-methyl-2-propenoic acid
2-Methyl-3-(hydroxymethyl)-3,4-dihydro-4-[[2-(3,4-dihydroxyphenyl)ethyloxy]carbonylmethyl]-2H-pyran-5-carboxylic acid methyl ester
(1R,6S,7R,8S,10R)-8,14-diacetoxy-1(10)-epoxy-15-hydroxygermacra-1(10),4,11(13)-trien-6,12-olide
(2E,8E,10E,12R)-tridecatriene-4,6-diyne-1,12,13-triol-1-O-beta-D-glucopyranoside
butyl 7-{(benzoyloxy)methyl}-3,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octane-3-carboxylate|decurrenside E
5,6-Dihydro-hypothemycin|5,6-dihydrohypothemycin|7,8-dihydrohypothemycin|dihydrohypothemycin
3beta,9beta-diacetoxy-1beta-hydroperoxy-6beta,7alphaH-germacra-4,10(14),11(13)-trien-12,6alpha-olide
3beta,13-diacetoxy-1beta-hydroxygermacra-4E,7(11),10(14)-triene-12,6alpha-olide
1,2-bis(4-hydroxy-3,5-dimethoxyphenyl)propane-1,3-diol
(1S*,2R*,5R*,6R*,7S*,8R*,9R*10S*)-2,9-diacetoxy-8,10-dihydroxyguaia-3,11(13)-diene-6,12-olide
1??,3??,15-Trihydroxy-3,10-epoxy-8??-O-methacryloyl-4,11-germacradiene,6??,12-olide
methyl 4-(4,6-dihydroxy-5-methoxy-2,5-dimethyl-3-oxocyclohexen-1-yl)oxy-2-hydroxy-3,6-dimethylbenzoate
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate
methyl 4-(4,6-dihydroxy-5-methoxy-2,5-dimethyl-3-oxocyclohexen-1-yl)oxy-2-hydroxy-3,6-dimethylbenzoate
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate [IIN-based on: CCMSLIB00000848087]
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate [IIN-based: Match]
Ser Ser Ser Thr
Ser Ser Thr Ser
Ser Thr Ser Ser
Thr Ser Ser Ser
Gibberellin A75
8-Oxodiacetoxyscirpenol
(S)-Bitalin A 12-glucoside
Gibberellin A86
Methyl helianthenoate A glucoside
Methyl 2-[(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxo-3-cyclohexen-1-yl)oxy]-4-hydroxy-3,6-dimethylbenzoate
(R)-3-((1-METHYLPYRROLIDIN-2-YL)METHYL)-5-(2-(PHENYLSULFONYL)VINYL)-1H-INDOLE
N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate
1-(2-AMINO-PHENYL)-PIPERIDINE-3-CARBOXYLICACIDETHYLESTER
XRP44X
XRP44X inhibits Ras-induced transcription activation with the IC50 of 10 nM. XRP44X inhibits activation of the Ras-Erk-1/2 pathway by FGF-2[1]. XRP44X is an inhibitor of Ras/Erk activation of Elk3 that also affects microtubules[2].
1-(2,4,6-TRIISOPROPYLBENZENESULFONYL)-3-NITRO-1H-1,2,4-TRIAZOLE
trabodenoson
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma[1].
3(S)-BOC-AMINO-2,3-DIHYDRO-4-OXO-1,5-BENZOTHIAZEPINE-5(2H)-ACETIC ACID ETHYL ESTER
(1R,2R,N1E,N2E)-N1,N2-bis(2-nitrobenzylidene)cyclohexane-1,2-diamine
diethyl 3,6-diphenyl-1,2,4,5-tetrazine-1,2-dicarboxylate
3-(1H-2-INDOLYL)-4-(4-METHOXYPHENYL)-1-METHYL-1H-2-QUINOLINONE
3-Pyridinecarboxamide, 2-(4-fluorophenoxy)-N-((4-(1-hydroxy-1-methylethyl)phenyl)methyl)-
Egtazic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
Cilastatin Sodium
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
Amosulalol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents